期刊
CURRENT MEDICINAL CHEMISTRY
卷 21, 期 36, 页码 4100-4131出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867321666140815124246
关键词
Alzheimer's disease; brain tumors; diagnosis; engineered nanomaterials; nanoscience; nanotechnology; Parkinson's disease
资金
- Spanish Ministry of Science and Innovation [SAF2010-15547]
- COST Action [TD1004]
- University of Navarra (FUN)
Nanomedicine has recently emerged as an exciting tool able to improve the early diagnosis and treatment of a variety of intractable or age-related brain disorders. The most relevant properties of nanomaterials are that they can be engineered to cross the blood brain barrier, to target specific cells and molecules and to act as vehicles for drugs. Potentially beneficial properties of nanotherapeutics derived from its unique characteristics include improved efficacy, safety, sensitivity and personalization compared to conventional medicines. In this review, recent advances in available nanostructures and nanomaterials for brain applications will be described. Then, the latest applications of nanotechnology for the diagnosis and treatment of neurological disorders, in particular brain tumors and neurodegenerative diseases, will be reviewed. Recent investigations of the neurotoxicity of the nanomaterial both in vitro and in vivo will be summarized. Finally, the ongoing challenges that have to be meet if new nanomedical products are to be put on the market will be discussed and some future directions will be outlined.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据